99 related articles for article (PubMed ID: 29241737)
1. Derivatization of honokiol by integrated acetylation and methylation for improved cutaneous delivery and anti-inflammatory potency.
Fang JY; Huang TH; Hung CF; Huang YL; Aljuffali IA; Liao WC; Lin CF
Eur J Pharm Sci; 2018 Mar; 114():189-198. PubMed ID: 29241737
[TBL] [Abstract][Full Text] [Related]
2. Methylation and Esterification of Magnolol for Ameliorating Cutaneous Targeting and Therapeutic Index by Topical Application.
Lin CF; Hung CF; Aljuffali IA; Huang YL; Liao WC; Fang JY
Pharm Res; 2016 Sep; 33(9):2152-67. PubMed ID: 27233503
[TBL] [Abstract][Full Text] [Related]
3. Maximizing dermal targeting and minimizing transdermal penetration by magnolol/honokiol methoxylation.
Lin CF; Hwang TL; Al-Suwayeh SA; Huang YL; Hung YY; Fang JY
Int J Pharm; 2013 Mar; 445(1-2):153-62. PubMed ID: 23380623
[TBL] [Abstract][Full Text] [Related]
4. Enhancement in the Transdermal and Localized Delivery of Honokiol Through Breast Tissue.
Gao X; Patel MG; Bakshi P; Sharma D; Banga AK
AAPS PharmSciTech; 2018 Nov; 19(8):3501-3511. PubMed ID: 30259402
[TBL] [Abstract][Full Text] [Related]
5. A novel transdermal honokiol formulation based on Pluronic F127 copolymer.
Zheng X; Wang X; Gou M; Zhang J; Men K; Chen L; Luo F; Zhao X; Wei Y; Qian Z
Drug Deliv; 2010 Apr; 17(3):138-44. PubMed ID: 20175649
[TBL] [Abstract][Full Text] [Related]
6. Subinhibitory concentrations of Honokiol reduce α-Hemolysin (Hla) secretion by
Guo N; Liu Z; Yan Z; Liu Z; Hao K; Liu C; Wang J
Emerg Microbes Infect; 2019; 8(1):707-716. PubMed ID: 31119985
[No Abstract] [Full Text] [Related]
7. Co-delivery of honokiol, a constituent of Magnolia species, in a self-microemulsifying drug delivery system for improved oral transport of lipophilic sirolimus.
Ding W; Hou X; Cong S; Zhang Y; Chen M; Lei J; Meng Y; Li X; Li G
Drug Deliv; 2016 Sep; 23(7):2513-2523. PubMed ID: 25835221
[TBL] [Abstract][Full Text] [Related]
8. Development of flavanone and its derivatives as topical agents against psoriasis: The prediction of therapeutic efficiency through skin permeation evaluation and cell-based assay.
Alalaiwe A; Lin CF; Hsiao CY; Chen EL; Lin CY; Lien WC; Fang JY
Int J Pharm; 2020 May; 581():119256. PubMed ID: 32220586
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus-loaded polymeric micelles with honokiol for oral delivery.
Li X; Hou X; Ding W; Cong S; Zhang Y; Chen M; Meng Y; Lei J; Liu Y; Li G
J Pharm Pharmacol; 2015 Dec; 67(12):1663-72. PubMed ID: 26454249
[TBL] [Abstract][Full Text] [Related]
10. Comparative inhibitory effects of magnolol, honokiol, eugenol and bis-eugenol on cyclooxygenase-2 expression and nuclear factor-kappa B activation in RAW264.7 macrophage-like cells stimulated with fimbriae of Porphyromonas gingivalis.
Murakami Y; Kawata A; Seki Y; Koh T; Yuhara K; Maruyama T; Machino M; Ito S; Kadoma Y; Fujisawa S
In Vivo; 2012; 26(6):941-50. PubMed ID: 23160676
[TBL] [Abstract][Full Text] [Related]
11. Anti-melasma codrug of retinoic acid assists cutaneous absorption with attenuated skin irritation.
Hsieh PW; Hung CF; Lin CH; Huang CW; Fang JY
Eur J Pharm Biopharm; 2017 May; 114():154-163. PubMed ID: 28161548
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of honokiol on lipopolysaccharide-induced cellular responses and signaling events in human renal mesangial cells.
Wu F; Zhang W; Li L; Zheng F; Shao X; Zhou J; Li H
Eur J Pharmacol; 2011 Mar; 654(1):117-21. PubMed ID: 21147091
[TBL] [Abstract][Full Text] [Related]
13. Honokiol inhibits ultraviolet radiation-induced immunosuppression through inhibition of ultraviolet-induced inflammation and DNA hypermethylation in mouse skin.
Prasad R; Singh T; Katiyar SK
Sci Rep; 2017 May; 7(1):1657. PubMed ID: 28490739
[TBL] [Abstract][Full Text] [Related]
14. Honokiol attenuates diet-induced non-alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator-activated receptor γ.
Zhong X; Liu H
J Gastroenterol Hepatol; 2018 Feb; 33(2):524-532. PubMed ID: 28670854
[TBL] [Abstract][Full Text] [Related]
15. Validation of cyclooxygenase-2 as a direct anti-inflammatory target of 4-O-methylhonokiol in zymosan-induced animal models.
Kim HS; Ryu HS; Kim JS; Kim YG; Lee HK; Jung JK; Kwak YS; Lee K; Seo SY; Yun J; Kang JS; Hong JT; Kim Y; Han SB
Arch Pharm Res; 2015; 38(5):813-25. PubMed ID: 25074039
[TBL] [Abstract][Full Text] [Related]
16. In vitro Penetration and in vivo Distribution of Honokiol into the Intervertebral Disc in Rat.
Chen CH; Chiang CJ; Wu LC; Yang CH; Kuo YJ; Tsai TH
Anal Sci; 2015; 31(12):1297-302. PubMed ID: 26656821
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling.
Lee J; Jung E; Park J; Jung K; Lee S; Hong S; Park J; Park E; Kim J; Park S; Park D
Planta Med; 2005 Apr; 71(4):338-43. PubMed ID: 15856410
[TBL] [Abstract][Full Text] [Related]
18. Chemopreventive effects of combination of honokiol and magnolol with α-santalol on skin cancer developments.
Chilampalli C; Zhang X; Kaushik RS; Young A; Zeman D; Hildreth MB; Fahmy H; Dwivedi C
Drug Discov Ther; 2013 Jun; 7(3):109-15. PubMed ID: 23917859
[TBL] [Abstract][Full Text] [Related]
19. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).
Godugu C; Doddapaneni R; Singh M
Colloids Surf B Biointerfaces; 2017 May; 153():208-219. PubMed ID: 28249200
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and metabolism of 4-O-methylhonokiol in rats.
Yu HE; Oh SJ; Ryu JK; Kang JS; Hong JT; Jung JK; Han SB; Seo SY; Kim YH; Park SK; Kim HM; Lee K
Phytother Res; 2014 Apr; 28(4):568-78. PubMed ID: 23824979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
